BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Back to all news

News focused on: Lab Lord S; Sandra Lord, MD; Type 1 Diabetes TrialNet; Type 1 Diabetes (T1D); Biorep Type 1 Diabetes

Monitoring T cells may allow prevention of type 1 diabetes

News Science in Seattle

January 9, 2023

Science in Seattle: A Promising New Approach to Stopping Type 1 Diabetes

News Science in Seattle

November 7, 2022

Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

Read the Publication ➡

October 13, 2022

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

Seattle, WA - Oct 5, 2022

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

Exploring autoimmunity's regulatory roots

January 14, 2022

Autoimmunity in Down Syndrome Arises From Rapid Immune Aging

News KUOW Newsroom

Do you need a Covid-19 booster shot? Seattle researchers aim to find out.

Gene-edited T cells to treat diabetes inch closer to clinical trials

News Science in Seattle

Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01

Biological 'atlas' shows dual personality for immune cells that cause type 1 diabetes

February 6, 2020

Screening Kids for Type 1 Diabetes in Primary Care Is Feasible

Blog T1D Diabetes Medical Technology

January 9, 2020

Bills in Washington State Would Lower Price of Insulin, Other Prescriptions

Seattle, WA - Dec 17, 2019

Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies

Blog T1D Diabetes Medical Technology

October 7, 2019

Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years

Watch video ➡

1 2 3 4 5

Back to all news